ENTITY
Clover Biopharmaceuticals

Clover Biopharmaceuticals (2197 HK)

45
Analysis
Health CareChina
Clover Biopharmaceuticals Limited operates as a clinical-stage biotechnology company. The Company develops novel vaccines and biologic therapeutic candidates for infectious diseases as well as cancer and autoimmune diseases. Clover Biopharmaceuticals provides services worldwide.
more
Refresh
bearishANE Logistics
10 Nov 2021 10:25

ANE Logistics IPO Trading - No Demand, We Would Stay Clear

ANE, an express freight network operator in China for less-than-truckload (LTL) market, raised around US$143m in its Hong Kong IPO. The company is...

Logo
273 Views
Share
bearishUju Holding
06 Nov 2021 09:21

Uju Holding IPO Trading - Downside Seems Imminent

Uju Holding (1948 HK) raised around US$106m after pricing its IPO at HKD6.90/share, at the bottom end of the IPO price range.

Logo
224 Views
Share
04 Nov 2021 13:51

Clover Biopharmaceuticals IPO: Thoughts on First Day Trading

Clover priced its IPO slightly below upper end of the price range and the IPO was moderately oversubscribed. We expect tomorrow's debut to be poor,...

Share
04 Nov 2021 12:27

Clover (三叶草生物) IPO Trading: Level for Accumulation

We look at factors for Clover Pharmaceuticals' debut performance. While the debut performance is likely to be poor, we would like to accumulate the...

Logo
135 Views
Share
bullishLi Ning
31 Oct 2021 09:56

ECM Weekly (31st October 2021) - Patym, PolicyBazaar, Nykaa, HeMo, Clover Bio, UJU, Airdoc, Mitratel

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Logo
195 Views
Share
x